Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 1 of 2 for:    VIVET
Previous Study | Return to List | Next Study

A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease (GATEWAY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04537377
Recruitment Status : Recruiting
First Posted : September 3, 2020
Last Update Posted : December 14, 2021
Information provided by (Responsible Party):
Vivet Therapeutics SAS

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 2023
Estimated Study Completion Date : July 2027